High levels of ZEB1, correlating with Fra-1 expression and melanoma stemness markers (MITFlo/p75hi in CSCs vs MITFhi/p75lo in non-CSCs) are implicated in intrinsic resistance to BRAF and MEK inhibitors. This evidence concerns the gene MAP2K7 and melanoma.